New Funding Opportunities Support Researchers, Communities of Color

Minority researchers and investigators from underrepresented communities often have access to less clinical research funding than other clinical researchers, according to Barbara Goodman, MBA, president and CEO of Cures Within Reach.

In an interview with Pharmacy Times, Goodman said new funding from the organization is aiming to improve these access issues specifically for clinical trials of repurposed drugs. Because repurposing trials often have fewer hurdles than de novo trials, the much-needed treatments could reach patients sooner. In order to support this research, Goodman said Cures Within Reach is in the process of selecting researchers to fund, both in the United States and internationally, and those selections will be completed by the end of the year.